David Matthew Friedman - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Reporting relationship: Director
Issuer ticker: MANE
Reported as of: 03 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Feb 2026, 19:04:54 UTC
Next SEC filing: 29 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Greco, Attorney-in-Fact

Key filing fact

David Matthew Friedman filed Form 4 for Veradermics, Inc (MANE) on 05 Feb 2026.

Key facts

This page summarizes David Matthew Friedman's Form 4 filing for Veradermics, Inc (MANE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Feb 2026, 19:04.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002108980 Primary reporting owner

Friedman David Matthew

Relationship: Director
Address: C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN
Signature: /s/ Michael Greco, Attorney-in-Fact
Signature date: 05 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MANE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +43,000
Change %
Price: $0.000000
Shares after: 43,000
Date: 03 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 43,000
Exercise price: $17.00
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Friedman in connection with his role as a member of the Issuer's Board of Directors. Mr. Friedman, as an employee of Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds"), is holding such options for the benefit of the Funds, and as such Mr. Friedman disclaims beneficial ownership of such options. The Funds, and Suvretta Capital may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Friedman's board service.

Footnote F2

This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.